Home›People›Tami Barr
Tami Barr

Tami Barr

Co-Founder and Chief Scientist, GOA Therapeutics

ExecutiveDirector
Updated Nov 7, 2026·Latest SEC filing Nov 5, 2026·Suggest an edit

About Tami Barr

Tami Barr is co-founder and chief scientist of GOA Therapeutics, a West Palm Beach company developing drugs for alcohol intoxication and poisoning. She is also a director of the company. She runs its science strategy, from drug discovery to research and development. She spent over ten years on drug discovery research, chiefly protein engineering, before she co-founded the company. That work became its scientific base.

Barr is a physician-scientist and inventor with more than 40 years of experience. She has held senior scientific and executive posts in pharmaceuticals, biotechnology, medical devices, agrotechnology and advanced technologies. She has been a president, a chief technology officer and a chief operating officer. She has also served as chief scientific officer and head of research and development. Her leadership experience has included Nano Dimension, Can-Fite Biopharma, RDD Pharma and ADAMA, which are now public companies. She holds an MD from the University of Cologne and a PhD from the Hebrew University of Jerusalem.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Tami Barr in the role, so the role may have started earlier or lasted longer.

GOA Therapeutics Corp Current
Co-Founder & Chief Scientist, director
2026 – Present · West Palm Beach, FL
A West Palm Beach drug developer working on GOA26, a candidate for alcohol intoxication and poisoning, preparing for an IND filing.

Key Colleagues at Startups

The people Tami Barr works with at each company, as listed on that company's latest Form D.

GOA Therapeutics Corp · Form D, Nov 5, 2026
Andrew Altschuler
Andrew Altschuler
Co-Founder & CEO, director
Dean Hakanson
Dean Hakanson
Chief Medical Officer
David Landesman
David Landesman
Chief Operating Officer

Sources

  1. SECGOA Therapeutics Corp Form D, filed Nov 5, 2026
  2. companyGOA Therapeutics home page